Immunotherapy Stocks List

Symbol Grade Name
CLDX Celldex Therapeutics, Inc.
FBIO Fortress Biotech, Inc.
NLNK NewLink Genetics Corporation
CDMO Avid Bioservices, Inc.
CVM Cel-Sci Corporation
IMUX Immunic, Inc.
GNCA Genocea Biosciences, Inc.
ENLV Enlivex Therapeutics Ltd.
DBVT DBV Technologies S.A.
APTO Aptose Biosciences, Inc.
BLCM Bellicum Pharmaceuticals, Inc.
IOVA Iovance Biotherapeutics, Inc.
CDTX Cidara Therapeutics, Inc.
ADAP Adaptimmune Therapeutics plc
ONCS OncoSec Medical Incorporated
CLBS Caladrius Biosciences, Inc.
ALPN Alpine Immune Sciences, Inc.
AIMT Aimmune Therapeutics, Inc.
PDSB PDS Biotechnology Corporation
SELB Selecta Biosciences, Inc.
MRKR Marker Therapeutics, Inc.
JNCE Jounce Therapeutics, Inc.
ARGX argenx SE
IMRN Immuron Limited
MBIO Mustang Bio, Inc.
FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
CDMOP Avid Bioservices, Inc. - 10.50% Series E Convertible Preferred Stock
RCUS Arcus Biosciences, Inc.
UMRX Unum Therapeutics Inc.
SURF Surface Oncology, Inc.
IMV IMV Inc.
REPL Replimune Group, Inc.
ARDS Aridis Pharmaceuticals Inc.
GRTS Gritstone Oncology, Inc.
AVCO Avalon GloboCare Corp.
INMB INmune Bio Inc.
HARP Harpoon Therapeutics, Inc.
TCRR TCR2 Therapeutics Inc.
DTIL Precision BioSciences, Inc.
NXTC NextCure, Inc.
LCTX Lineage Cell Therapeutics, Inc.

Recent Signals

Date Stock Signal Type
2019-09-17 ADAP Doji - Bullish? Reversal
2019-09-17 ADAP Calm After Storm Range Contraction
2019-09-17 AIMT Calm After Storm Range Contraction
2019-09-17 AIMT Slingshot Bullish Bullish Swing Setup
2019-09-17 AIMT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-17 AIMT NR7 Range Contraction
2019-09-17 ALPN Calm After Storm Range Contraction
2019-09-17 ALPN 50 DMA Resistance Bearish
2019-09-17 APTO Fell Below 20 DMA Bearish
2019-09-17 APTO NR7 Range Contraction
2019-09-17 ARDS 180 Bearish Setup Bearish Swing Setup
2019-09-17 ARGX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-09-17 ARGX Narrow Range Bar Range Contraction
2019-09-17 ARGX 1,2,3 Retracement Bearish Bearish Swing Setup
2019-09-17 AVCO Upper Bollinger Band Walk Strength
2019-09-17 BLCM Fell Below 20 DMA Bearish
2019-09-17 CDMO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-09-17 CDTX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-17 CDTX Narrow Range Bar Range Contraction
2019-09-17 CDTX 1,2,3 Pullback Bullish Bullish Swing Setup
2019-09-17 CLBS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-17 CLBS Crossed Above 50 DMA Bullish
2019-09-17 CLBS Wide Range Bar Range Expansion
2019-09-17 CLBS Pocket Pivot Bullish Swing Setup
2019-09-17 CLBS Crossed Above 20 DMA Bullish
2019-09-17 CLDX NR7 Range Contraction
2019-09-17 CVM New 52 Week High Strength
2019-09-17 CVM Wide Range Bar Range Expansion
2019-09-17 DBVT Fell Below 50 DMA Bearish
2019-09-17 DTIL Upper Bollinger Band Walk Strength
2019-09-17 DTIL Calm After Storm Range Contraction
2019-09-17 DTIL 1,2,3 Pullback Bullish Bullish Swing Setup
2019-09-17 DTIL Boomer Buy Setup Bullish Swing Setup
2019-09-17 ENLV Upper Bollinger Band Walk Strength
2019-09-17 ENLV Narrow Range Bar Range Contraction
2019-09-17 ENLV Calm After Storm Range Contraction
2019-09-17 ENLV New 52 Week Closing High Bullish
2019-09-17 ENLV Jack-in-the-Box Bullish Bullish Swing Setup
2019-09-17 FBIO MACD Bearish Signal Line Cross Bearish
2019-09-17 FBIO Bollinger Band Squeeze Range Contraction
2019-09-17 FBIOP Lower Bollinger Band Walk Weakness
2019-09-17 GNCA NR7-2 Range Contraction
2019-09-17 GNCA NR7 Range Contraction
2019-09-17 GNCA Narrow Range Bar Range Contraction
2019-09-17 GRTS 20 DMA Resistance Bearish
2019-09-17 IMRN 20 DMA Support Bullish
2019-09-17 IMRN Bollinger Band Squeeze Range Contraction
2019-09-17 IMV Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-17 IMV 20 DMA Support Bullish
2019-09-17 IMV 50 DMA Support Bullish
2019-09-17 INMB Crossed Above 20 DMA Bullish
2019-09-17 INMB NR7 Range Contraction
2019-09-17 INMB Spinning Top Other
2019-09-17 IOVA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-09-17 IOVA NR7 Range Contraction
2019-09-17 JNCE Bollinger Band Squeeze Range Contraction
2019-09-17 JNCE Doji - Bullish? Reversal
2019-09-17 MRKR Pocket Pivot Bullish Swing Setup
2019-09-17 MRKR 50 DMA Support Bullish
2019-09-17 MRKR Crossed Above 200 DMA Bullish
2019-09-17 NLNK Upper Bollinger Band Walk Strength
2019-09-17 NXTC Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-17 NXTC 1,2,3 Pullback Bullish Bullish Swing Setup
2019-09-17 ONCS Expansion Pivot Buy Setup Bullish Swing Setup
2019-09-17 ONCS Crossed Above 50 DMA Bullish
2019-09-17 ONCS Pocket Pivot Bullish Swing Setup
2019-09-17 RCUS Upper Bollinger Band Walk Strength
2019-09-17 RCUS Pocket Pivot Bullish Swing Setup
2019-09-17 RCUS 200 DMA Resistance Bearish
2019-09-17 REPL 200 DMA Resistance Bearish
2019-09-17 REPL Pocket Pivot Bullish Swing Setup
2019-09-17 REPL Upper Bollinger Band Walk Strength
2019-09-17 SELB Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-17 SELB 20 DMA Support Bullish
2019-09-17 SURF Bollinger Band Squeeze Range Contraction
2019-09-17 SURF Wide Range Bar Range Expansion
2019-09-17 SURF Bearish Engulfing Bearish
2019-09-17 SURF Fell Below 50 DMA Bearish
2019-09-17 TCRR 1,2,3 Pullback Bullish Bullish Swing Setup
2019-09-17 TCRR Doji - Bullish? Reversal
2019-09-17 TCRR Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-17 UMRX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-09-17 UMRX Fell Below 50 DMA Bearish

Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.

More about Immunotherapy